Body-mass index and mortality among 1

Author(s): Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, et al.

Abstract

Background: A high body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is associated with increased mortality from cardiovascular disease and certain cancers, but the precise relationship between BMI and all-cause mortality remains uncertain.

Methods: We used Cox regression to estimate hazard ratios and 95% confidence intervals for an association between BMI and all-cause mortality, adjusting for age, study, physical activity, alcohol consumption, education, and marital status in pooled data from 19 prospective studies encompassing 1.46 million white adults, 19 to 84 years of age (median, 58).

Results: The median baseline BMI was 26.2. During a median follow-up period of 10 years (range, 5 to 28), 160,087 deaths were identified. Among healthy participants who never smoked, there was a J-shaped relationship between BMI and all-cause mortality. With a BMI of 22.5 to 24.9 as the reference category, hazard ratios among women were 1.47 (95 percent confidence interval [CI], 1.33 to 1.62) for a BMI of 15.0 to 18.4; 1.14 (95% CI, 1.07 to 1.22) for a BMI of 18.5 to 19.9; 1.00 (95% CI, 0.96 to 1.04) for a BMI of 20.0 to 22.4; 1.13 (95% CI, 1.09 to 1.17) for a BMI of 25.0 to 29.9; 1.44 (95% CI, 1.38 to 1.50) for a BMI of 30.0 to 34.9; 1.88 (95% CI, 1.77 to 2.00) for a BMI of 35.0 to 39.9; and 2.51 (95% CI, 2.30 to 2.73) for a BMI of 40.0 to 49.9. In general, the hazard ratios for the men were similar. Hazard ratios for a BMI below 20.0 were attenuated with longer-term follow-up.

Conclusions: In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality. All-cause mortality is generally lowest with a BMI of 20.0 to 24.9.

Similar Articles

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality

Author(s): Chang Y, Schechter CB, van Ravesteyn NT, Near AM, Heijnsdijk EA, et al.

Cost-effectiveness of screening for colorectal cancer in the general population

Author(s): Frazier AL, Colditz GA, Fuchs CS, Kuntz KM

50-year trends in smoking-related mortality in the United States

Author(s): Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, et al.

Body-mass index and mortality in a prospective cohort of U

Author(s): Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr

Weight Control and Physical Activity

Author(s): Vainio H, Kaaks R, Bianchini F

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer

Author(s): Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, et al.

Alcohol consumption and mortality among middle-aged and elderly U

Author(s): Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, et al.

Aspirin use and reduced risk of fatal colon cancer

Author(s): Thun MJ, Namboodiri MM, Heath CW Jr

A randomized trial of aspirin to prevent colorectal adenomas

Author(s): Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, et al.

Aspirin and the risk of colorectal cancer in women

Author(s): Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, et al.

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

Author(s): Flossmann E, Rothwell PM; British Doctors Aspirin Trial and the UK-TIA Aspirin Trial

Breast cancer and hormone replacement therapy

Author(s): [No authors listed]

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

Author(s): Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, et al.

Identification of a new prostate cancer susceptibility locus on chromosome 8q24

Author(s): Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, et al.

Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality

Author(s): McCullough ML, Patel AV, Kushi LH, Patel R, Willett WC, et al.

Transforming epidemiology for 21st century medicine and public health

Author(s): Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, et al.

The economic costs of non-insulin-dependent diabetes mellitus

Author(s): Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA

Prevention of venous thromboembolism after general surgery

Author(s): Oster G, Tuden RL, Colditz GA

Cost-effectiveness of cervical-cancer screening in five developing countries

Author(s): Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, et al.